Sensory hypoinnervation in club foot
- 期刊名称The Journal of Bone and Joint Surgery
- 作者Ahmed, M.; Ahmed, N.; Khan, K.M.; Umer, M.; Rashid, H.; Hashmi, P.; Umar, M.
- 卷第86卷
- 期第8期
- 印刷ISSN0301-620X
- 电子ISSN0000-0000
- 文件大小353.92KB
- 发表时间2004-11-01
- DOI10.1302/0301-620X.86B8.14305
- 页码1163-1169
Chimeric antigen receptor–engineered T cells for liver cancers, progress and obstaclesLi, Keyu; Lan, Yaliang; Wang, Jiabei; Liu, Lianxin · Tumor Biology · 2017
Chimeric antigen receptor engineered natural killer and natural killer T cells for cancer immunotherapyBollino, Dominique; Webb, Tonya J. · Translational Research · 2017
Preclinical evaluation of CD38 chimeric antigen receptor engineered T cells for the treatment of multiple myelomaEsther Drent,Richard Groen,Willy Noort… · Journal for ImmunoTherapy of Cancer · 2015
Claudin18.2-Specific Chimeric Antigen Receptor Engineered T Cells for the Treatment of Gastric CancerJiang, Hua; Shi, Zhimin; Wang, Peng; Wang, Cong; Yang, Linlin; Du, Guoxiu; Zhang, Honghong; Shi, Bizhi; Jia, Jie; Li, Qixiang; Wang, Huamao; Li, Zonghai · JNCI: Journal of the National Cancer Institute · 2018
Pre-clinical evaluation of CD38 chimeric antigen receptor engineered T cells for the treatment of multiple myelomaDrent, E.; Groen, R. W. J.; Noort, W. A.; Themeli, M.; Lammerts van Bueren, J. J.; Parren, P. W. H. I.; Kuball, J.; Sebestyen, Z.; Yuan, H.; de Bruijn, J.; van de Donk, N. W. C. J.; Martens, A. C. M.; Lokhorst, H. M.; Mutis, T. · Haematologica · 2016
Improvement of in vitro potency assays by a resting step for clinical-grade chimeric antigen receptor engineered T cellsWANG, LEI; GONG, WENJIE; WANG, SANMEI; NEUBER, BRIGITTE; SELLNER, LEOPOLD; SCHUBERT, MARIA-LUISA; HÜCKELHOVEN-KRAUSS, ANGELA; KUNZ, ALEXANDER; GERN, ULRIKE; MICHELS, BIRGIT; HINKELBEIN, MANDY; MECHLER, STEFANIE; RICHTER, PETRA; MÜLLER-TIDOW, CARSTEN; SCHMITT, MICHAEL; SCHMITT, ANITA · Cytotherapy · 2019
Systemic treatment with CAR-engineered T cells against PSCA delays subcutaneous tumor growth and prolongs survival of miceHillerdal, Victoria; Ramachandran, Mohanraj; Leja, Justyna; Essand, Magnus · BMC Cancer · 2014
Allogeneic lymphocyte-licensed DCs expand T cells with improved antitumor activity and resistance to oxidative stress and immunosuppressive factorsJin, Chuan; Yu, Di; Hillerdal, Victoria; Wallgren, AnnaCarin; Karlsson-Parra, Alex; Essand, Magnus · Molecular Therapy — Methods & Clinical Development · 2014
MicroRNA EpigeneticsBavan, Luckshman; Midwood, Kim; Nanchahal, Jagdeep · BioDrugs · 2011
Immunotherapy of Multiple SclerosisKarussis, Dimitrios · BioDrugs · 2013
RituximabAbdulla, Nihal E.; Ninan, Mary J.; Markowitz, Avi B. · BioDrugs · 2012
IpilimumabSanford, Mark · BioDrugs · 2012
Rotavirus VaccineBernstein, David I. · BioDrugs · 2000
Belimumab Therapy in Systemic Lupus ErythematosusZouali, Moncef; Uy, Eugene A. · BioDrugs · 2013
Strategies for Targeting Tetraspanin ProteinsHassuna, Noha; Monk, Peter N.; Moseley, Gregory W.; Partridge, Lynda J. · BioDrugs · 2009
MicroRNA-Based Therapeutics for CancerWang, Vivien; Wu, Wei · BioDrugs · 2009